4Front Ventures (FFNT) Stock Overview
Engages in cultivating, processing, manufacturing, and sale of cannabis products in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
FFNT Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
4Front Ventures Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.005 |
| 52 Week High | CA$0.15 |
| 52 Week Low | CA$0.005 |
| Beta | 1.37 |
| 1 Month Change | 0% |
| 3 Month Change | -80.00% |
| 1 Year Change | -95.65% |
| 3 Year Change | -99.30% |
| 5 Year Change | -99.02% |
| Change since IPO | -99.55% |
Recent News & Updates
Recent updates
4Front Ventures Corp.'s (CSE:FFNT) Price Is Right But Growth Is Lacking After Shares Rocket 33%
Feb 09
Investors Don't See Light At End Of 4Front Ventures Corp.'s (CSE:FFNT) Tunnel And Push Stock Down 40%
Dec 26More Unpleasant Surprises Could Be In Store For 4Front Ventures Corp.'s (CSE:FFNT) Shares After Tumbling 29%
Nov 08Investors Give 4Front Ventures Corp. (CSE:FFNT) Shares A 33% Hiding
Aug 15Market Cool On 4Front Ventures Corp.'s (CSE:FFNT) Revenues Pushing Shares 34% Lower
Feb 16Little Excitement Around 4Front Ventures Corp.'s (CSE:FFNT) Earnings As Shares Take 28% Pounding
Jun 13Health Check: How Prudently Does 4Front Ventures (CSE:FFNT) Use Debt?
Jun 07Is 4Front Ventures (CSE:FFNT) Using Too Much Debt?
Jan 084Front Ventures (CSE:FFNT) Is Making Moderate Use Of Debt
Sep 08Shareholder Returns
| FFNT | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | -1.4% | 0.4% |
| 1Y | -95.7% | -54.2% | 18.9% |
Return vs Industry: FFNT underperformed the Canadian Pharmaceuticals industry which returned -54.2% over the past year.
Return vs Market: FFNT underperformed the Canadian Market which returned 18.9% over the past year.
Price Volatility
| FFNT volatility | |
|---|---|
| FFNT Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 12.6% |
| Market Average Movement | 9.6% |
| 10% most volatile stocks in CA Market | 18.4% |
| 10% least volatile stocks in CA Market | 3.9% |
Stable Share Price: FFNT's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: Insufficient data to determine FFNT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 387 | Andrew Thut | 4frontventures.com |
4Front Ventures Corp. engages in cultivating, processing, manufacturing, and sale of cannabis products in the United States. The company operates through three segments: Illinois, Massachusetts, and Corporate. It offers flower, pre-rolls, vaporizers, concentrates, edibles, tinctures and soft gels, capsules, and topicals, as well as provides a vertically integrated supply chain to serve both medical and recreational markets.
4Front Ventures Corp. Fundamentals Summary
| FFNT fundamental statistics | |
|---|---|
| Market cap | CA$4.58m |
| Earnings (TTM) | -CA$48.09m |
| Revenue (TTM) | CA$103.27m |
Is FFNT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FFNT income statement (TTM) | |
|---|---|
| Revenue | US$75.61m |
| Cost of Revenue | US$48.71m |
| Gross Profit | US$26.90m |
| Other Expenses | US$62.11m |
| Earnings | -US$35.21m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.038 |
| Gross Margin | 35.57% |
| Net Profit Margin | -46.57% |
| Debt/Equity Ratio | -175.3% |
How did FFNT perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/18 12:17 |
| End of Day Share Price | 2025/05/08 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
4Front Ventures Corp. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jonathan DeCourcey | BTIG |
| Matt Bottomley | Canaccord Genuity |
| Ty Collin | Eight Capital |